Vassilios Myrianthopoulos

Citado por

	Total	Desde 2020
Citas	2290	1033
Índice h	23	18
Índice i10	35	29

240

120

180

200420052006200720082009201020112012201320142015201620172018201920202021202220232024202514 24 29 26 31 50 64 72 66 101 122 105 121 138 114 165 200 230 204 196 181 22

Acceso público

Ver todo

15 artículos

5 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Emmanuel MikrosProfessor, Pharmaceutical Chemistry, Pharmacy, National and Kapodistrian University of AthensDirección de correo verificada de pharm.uoa.gr
Alexios-Leandros SkaltsounisSchool of Pharmacy, National and Kapodistrian University of AthensDirección de correo verificada de pharm.uoa.gr
Vassilis GorgoulisProfessor Histology-Embryology, Medical School, National Kapodistrian University of AthensDirección de correo verificada de med.uoa.gr
Andreas PapapetropoulosNational and Kapodistrian University of AthensDirección de correo verificada de pharm.uoa.gr
Dimitris ThanosChairman of the Scientific Board, Biomedical Research Foundation Academy of AthensDirección de correo verificada de bioacademy.gr
Grigoris ZoidisAssistant Professor of Pharmaceutical/Medicinal ChemistryDirección de correo verificada de pharm.uoa.gr
Konstantinos VougasResearch Scientist, Biomedical Research Foundation of the Academy of AthensDirección de correo verificada de bioacademy.gr
Ioannis TrougakosNational and Kapodistrian University of Athens, Faculty of BiologyDirección de correo verificada de biol.uoa.gr
Stefan KnappUniversity of FrankfurtDirección de correo verificada de pharmchem.uni-frankfurt.de
Panagis FilippakopoulosAssociate Professor, Oxford UniversityDirección de correo verificada de sgc.ox.ac.uk
Daniel CappelSchrödingerDirección de correo verificada de schrodinger.com
Nikolas FokialakisAss. Prof. National and Kapodistrian University of AthensDirección de correo verificada de pharm.uoa.gr
Woody ShermanPsivant TherapeuticsDirección de correo verificada de psivant.com
Annelies StevaertPost-Doc, Rega Institute for Medical Research, KU LeuvenDirección de correo verificada de kuleuven.be
Oleg FedorovUniversity of OxfordDirección de correo verificada de cmd.ox.ac.uk
Michelle Lynn HallModerna TherapeuticsDirección de correo verificada de modernatx.com
Christian BronnerInserm, CNRS, Université de StrasbourgDirección de correo verificada de igbmc.fr
Daumantas MatulisHead of Department of Biothermodynamics and Drug Design, Vilnius University Institute ofDirección de correo verificada de bti.vu.lt
Saulius KlimašauskasInstitute of Biotechnology, Life Sciences Center, Vilnius UniversityDirección de correo verificada de ibt.lt
Meletios Athanasios DimopoulosNational and Kapodistrian University of Athens, School of MedicineDirección de correo verificada de med.uoa.gr

Seguir

Vassilios Myrianthopoulos

Assistant Professor, National and Kapodistrian University of Athens

Dirección de correo verificada de pharm.uoa.gr

Medicinal Chemistry Rational Drug Design Virtual screening Biophysics Epigenetics


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases P Polychronopoulos, P Magiatis, AL Skaltsounis, V Myrianthopoulos, ... Journal of medicinal chemistry 47 (4), 935-946, 2004	496	2004
Roscovitine-derived, dual-specificity inhibitors of cyclin-dependent kinases and casein kinases 1 N Oumata, K Bettayeb, Y Ferandin, L Demange, A Lopez-Giral, ... Journal of medicinal chemistry 51 (17), 5229-5242, 2008	202	2008
Senescence and senotherapeutics: a new field in cancer therapy V Myrianthopoulos, K Evangelou, PVS Vasileiou, T Cooks, ... Pharmacology & therapeutics 193, 31-49, 2019	188	2019
Soluble 3′, 6-substituted indirubins with enhanced selectivity toward glycogen synthase kinase-3 alter circadian period K Vougogiannopoulou, Y Ferandin, K Bettayeb, V Myrianthopoulos, ... Journal of medicinal chemistry 51 (20), 6421-6431, 2008	136	2008
Machine learning and data mining frameworks for predicting drug response in cancer: An overview and a novel in silico screening process based on association rule mining K Vougas, T Sakellaropoulos, A Kotsinas, GRP Foukas, A Ntargaras, ... Pharmacology & therapeutics 203, 107395, 2019	122	2019
6-Br-5methylindirubin-3′ oxime (5-Me-6-BIO) targeting the leishmanial glycogen synthase kinase-3 (GSK-3) short form affects cell-cycle progression and induces apoptosis-like … E Xingi, D Smirlis, V Myrianthopoulos, P Magiatis, KM Grant, L Meijer, ... International journal for parasitology 39 (12), 1289-1303, 2009	96	2009
Novel inverse binding mode of indirubin derivatives yields improved selectivity for DYRK kinases V Myrianthopoulos, M Kritsanida, N Gaboriaud-Kolar, P Magiatis, ... ACS Medicinal Chemistry Letters 4 (1), 22-26, 2013	80	2013
An integrated computational approach to the phenomenon of potent and selective inhibition of aurora kinases B and C by a series of 7-substituted indirubins V Myrianthopoulos, P Magiatis, Y Ferandin, AL Skaltsounis, L Meijer, ... Journal of medicinal chemistry 50 (17), 4027-4037, 2007	73	2007
Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a … N Druzhyna, B Szczesny, G Olah, K Módis, A Asimakopoulou, A Pavlidou, ... Pharmacological research 113, 18-37, 2016	71	2016
Discovery and optimization of a selective ligand for the switch/sucrose nonfermenting-related bromodomains of polybromo protein-1 by the use of virtual screening and hydration … V Myrianthopoulos, N Gaboriaud-Kolar, C Tallant, ML Hall, S Grigoriou, ... Journal of Medicinal Chemistry 59 (19), 8787-8803, 2016	58	2016
Two new peltogynoids from Acacia nilotica Delile with kinase inhibitory activity A Ahmadu, A Abdulkarim, R Grougnet, V Myrianthopoulos, F Tillequin, ... Planta medica 76 (05), 458-460, 2010	54	2010
Identification of the substrate recognition and transport pathway in a eukaryotic member of the nucleobase-ascorbate transporter (NAT) family V Kosti, G Lambrinidis, V Myrianthopoulos, G Diallinas, E Mikros PLoS One 7 (7), e41939, 2012	53	2012
Selective cytotoxicity of the herbal substance acteoside against tumor cells and its mechanistic insights C Cheimonidi, P Samara, P Polychronopoulos, EN Tsakiri, T Nikou, ... Redox Biology 16, 169-178, 2018	52	2018
Modeling, substrate docking, and mutational analysis identify residues essential for the function and specificity of a eukaryotic purine-cytosine NCS1 transporter E Krypotou, V Kosti, S Amillis, V Myrianthopoulos, E Mikros, G Diallinas Journal of Biological Chemistry 287 (44), 36792-36803, 2012	52	2012
Tandem virtual screening targeting the SRA domain of UHRF1 identifies a novel chemical tool modulating DNA methylation V Myrianthopoulos, PF Cartron, Z Liutkevičiūtė, S Klimašauskas, ... European journal of medicinal chemistry 114, 390-396, 2016	51	2016
Exploring and exploiting the systemic effects of deregulated replication licensing TG Petrakis, ES Komseli, M Papaioannou, K Vougas, A Polyzos, ... Seminars in Cancer Biology 37, 3-15, 2016	43	2016
An inhibitor-driven study for enhancing the selectivity of indirubin derivatives towards leishmanial Glycogen Synthase Kinase-3 over leishmanial cdc2-related protein kinase 3 A Efstathiou, N Gaboriaud-Kolar, D Smirlis, V Myrianthopoulos, ... Parasites & vectors 7, 1-12, 2014	43	2014
A substrate translocation trajectory in a cytoplasm‐facing topological model of the monocarboxylate/H⁺ symporter Jen1p I Soares‐Silva, J Sá‐Pessoa, V Myrianthopoulos, E Mikros, M Casal, ... Molecular microbiology 81 (3), 805-817, 2011	32	2011
Investigating and re-evaluating the role of glycogen synthase kinase 3 beta kinase as a molecular target for cardioprotection by using novel pharmacological inhibitors PE Nikolaou, K Boengler, P Efentakis, K Vouvogiannopoulou, A Zoga, ... Cardiovascular research 115 (7), 1228-1243, 2019	30	2019
The emerging field of senotherapeutic drugs V Myrianthopoulos Future medicinal chemistry 10 (20), 2369-2372, 2018	30	2018

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores